Polymorphic repeats in the androgen receptor gene in high-risk sibships

被引:34
作者
Miller, EA
Stanford, JL
Hsu, L
Noonan, E
Ostrander, EA
机构
[1] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA
[3] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[4] Univ Washington, Dept Urol, Seattle, WA 98195 USA
关键词
androgen receptor; genetic polymorphism; prostate cancer; family studies; microsatellites;
D O I
10.1002/pros.1098
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Genetic susceptibility may explain some familial clusters of prostate cancer. The polymorphic androgen receptor (AR) gene, which mediates androgen activity in the prostate, is a candidate gene that may influence predisposition to the disease. METHODS. We analyzed the polymorphic (CAG)n and (GGN)n repeats within the AR gene in men from 51 high-risk prostate cancer sibships, which included at least one affected and one unaffected man (n = 210). We compared repeat lengths of men with prostate cancer (n = 140) to their brothers (n = 70) without disease, stratified by median age at diagnosis of affected men within each sibship. Conditional logistic regression was used to compute odds ratios (OR) and 95% confidence intervals to evaluate associations between prostate cancer and repeat length. RESULTS. The OR for prostate cancer associated with short (CAG)n repeats (< 22) compared to longer repeats (greater than or equal to 22) was 1.13 (95% CI 0.5-2.4) overall, but was higher in sibships with a median age of < 66 years at diagnosis (OR = 1.72, 95% CI 0.5-6.0). The (GGN)n array also was not associated with prostate cancer in general. However, in older men (greater than or equal to 66 years), there was a modest elevation in risk (OR = 1.56, 95% CI 0.6-4.1) among those with short repeats (GGN of less than or equal to 16). Men with both a short (CAG)n (< 22) and a short (GGN)n (less than or equal to 16) array were not at higher risk (OR = 1.06) compared to men with two long repeats [((CAG)n greater than or equal to 22 and (GGN)n > 16)]. CONCLUSIONS. These results suggest that the (CAG)n and (GGN)n repeats in the AR gene do not play a major role in familial prostate cancer.
引用
收藏
页码:200 / 205
页数:6
相关论文
共 21 条
  • [1] Breslow NE, 1980, STAT METHODS CANC RE, V1, DOI DOI 10.1097/00002030-199912240-00009
  • [2] THE HUMAN ANDROGEN RECEPTOR - DOMAIN-STRUCTURE, GENOMIC ORGANIZATION AND REGULATION OF EXPRESSION
    BRINKMANN, AO
    FABER, PW
    VANROOIJ, HCJ
    KUIPER, GGJM
    RIS, C
    KLAASSEN, P
    VANDERKORPUT, JAGM
    VOORHORST, MM
    VANLAAR, JH
    MULDER, E
    TRAPMAN, J
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1989, 34 (1-6) : 307 - 310
  • [3] BROWN TR, 1988, P NATL ACAD SCI USA, V85, P8185
  • [4] THE LENGTH AND LOCATION OF CAG TRINUCLEOTIDE REPEATS IN THE ANDROGEN RECEPTOR N-TERMINAL DOMAIN AFFECT TRANSACTIVATION FUNCTION
    CHAMBERLAIN, NL
    DRIVER, ED
    MIESFELD, RL
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (15) : 3181 - 3186
  • [5] GENETIC-VARIATION AT 5 TRIMERIC AND TETRAMERIC TANDEM REPEAT LOCI IN 4 HUMAN-POPULATION GROUPS
    EDWARDS, A
    HAMMOND, HA
    JIN, L
    CASKEY, CT
    CHAKRABORTY, R
    [J]. GENOMICS, 1992, 12 (02) : 241 - 253
  • [6] THE STEROID AND THYROID-HORMONE RECEPTOR SUPERFAMILY
    EVANS, RM
    [J]. SCIENCE, 1988, 240 (4854) : 889 - 895
  • [7] Gauderman W. James, 1999, Journal of the National Cancer Institute Monographs, P31
  • [8] The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
    Giovannucci, E
    Stampfer, MJ
    Krithivas, K
    Brown, M
    Brufsky, A
    Talcott, J
    Hennekens, CH
    Kantoff, PW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) : 3320 - 3323
  • [9] CARCINOMA OF THE PROSTATE
    GITTES, RF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (04) : 236 - 245
  • [10] Cancer statistics, 2001
    Greenlee, RT
    Hill-Harmon, MB
    Murray, T
    Thun, M
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) : 15 - 36